DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein ...(hly expressed native E. coli genes rathe...)

"DNA2.0 has discovered the 'Rosetta stone' for determining the best codon choices, which means that we can design genes for our customers that are guaranteed for high expression yields," said Jeremy Minshull, president of DNA2.0. "The PLoS ONE publication nicely complements the broad and fundamental patents we were recently awarded for this technology; peer review is essential for scientific credibility, and none of our competitors can come close to this."

Together with the recently released pJexpress E. coli expression vectors, DNA2.0's patented gene optimization technology offers the most integrated and efficient path from virtual sequence to expressed protein. While many other gene synthesis companies offshore manufacturing to areas of the world with lax IP protection, all DNA2.0 genes are made at the company's state-of-the-art facility in Menlo Park, thus ensuring the greatest security for patented or confidential sequences. DNA2.0 guarantees researchers high quality synthetic genes, delivered on time, every time.

About DNA2.0:
Founded in 2003, DNA2.0 is the leading synthetic genomics company. It is the fastest provider of synthetic genes, based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 has provided genes to thousands of customers, for whom it has synthesized many millions of base pairs. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene synthesis process and new protein optimization technologies. The tools and applications brought to market by DNA2.0 are transforming biology into an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information
'/>"/>